AZ announces results delay for key lung cancer trial

12th March 2018 Uncategorised 0

AstraZeneca and research arm MedImmune have announced a longer wait for survival data from a closely-watched trial testing Imfinzi in advanced lung cancer.

More: AZ announces results delay for key lung cancer trial
Source: News